SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Qualcomm Moderated Thread - please read rules before posting -- Ignore unavailable to you. Want to Upgrade?

To: JGoren who wrote (48294)11/1/2005 5:50:14 PM
From: kech  Read Replies (1) | Respond to of 196972
 
I guess it depends on the terms of the license. If the license is "very low" would you consider investing in Roche when they decide to invest again in vaccine viruses?



To: JGoren who wrote (48294)11/1/2005 6:21:29 PM
From: SirWalterRalegh  Respond to of 196972
 
I do think the US govt ought to build a plant in the US and make Tamiflu under a license. I am shocked to read that Roche is refusing to license manufacture since it can't make enough.

J-

Is it not true that US law allows the manufacture of any patented product
that the patent holder cannot make enough of to satisfy demand?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News